Normal view MARC view ISBD view

Evaluation of Early Infant Diagnosis of HIV 1 in Government hospital, Dhule. [electronic resource]

By:

Dravid, Mrudula Nandkumar

Contributor(s):

Producer: 20131101Description: 2104 p. digitalISSN:

2249-782X

Online resources:

Available from publisher's website

In: Journal of clinical and diagnostic research : JCDR vol. 7

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 New insights on translational development of mesenchymal stromal cells for suppressor therapy.
by François, Moïra
2 Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells.
by Coutu, Daniel L
3 Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.
by François, Moïra
4 Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.
by Eliopoulos, Nicoletta
5 Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation.
by Mercier, François
6 Adoptive transfer of mesenchymal stromal cells accelerates intestinal epithelium recovery of irradiated mice in an interleukin-6-dependent manner.
by François, Moïra
7 Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy.
by Eliopoulos, Nicoletta
8 Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density.
by Romieu-Mourez, Raphaëlle
9 A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex.
by Rafei, Moutih
10 Two distinct CXCR4 antagonists mobilize progenitor cells in mice by different mechanisms.
by Redpath, Andia N
11 Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients.
by Campeau, Philippe M
12 Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.
by Romieu-Mourez, Raphaëlle
13 Plasminogen Kringle 5 blocks tumor progression by antiangiogenic and proinflammatory pathways.
by Perri, Sabrina R
14 Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing.
by François, Moïra
15 Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties.
by François, Moïra
16 Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
by Cuerquis, Jessica
17 Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
by Perri, Sabrina R
18 Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis.
by Darlington, Peter J
19 Hierarchical scaffold design for mesenchymal stem cell-based gene therapy of hemophilia B.
by Coutu, Daniel L
20 Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming.
by Romieu-Mourez, Raphaëlle